D041: Ferroptosis and phospholipid metabolism for chemo- and immunotherapy sensitization in urothelial cancer
FAU own research funding: EFI / IZKF / EAM ...
Start date :
01.07.2023
End date :
31.12.2025
Extension date:
30.06.2026
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer (2024)
Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, et al.
Journal article
AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024)
Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al.
Journal article
Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition (2024)
Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenkäs K, Bindel N, D’Avanzo E, et al.
Journal article